-
Original Article
-
Korean J Med. 2008;75(3):823-826.
- 증례 : Alemtuzumab에 반응을 보인 불응성 만성 림파구성 백혈병의 1예
-
김경희.최문기.홍정용.하영은.김민영.김윤정.김원석, , , , , ,
-
- A refractory chronic lymphocytic leukemia patient who responded to alemtuzumab
-
Kyung Hee Kim, Moon Ki Choi, Jung Yong Hong, Young Eun Ha, Min Young Kim, Yoon Jung Kim, Won Seog Kim
-
-
- Abstract
- Chronic lymphocytic leukemia (CLL) has a relatively slow clinical course, but death is almost inevitable within a few years once the disease progresses. The prognosis in cases of CLL that become refractory to a previous chemotherapeutic agent is especially poor, and new modalities are needed to treat CLL. We experienced a case of chemorefractory CLL transformed from small lymphocytic lymphoma that responded to alemtuzumab. We report this case and review the literature. (Korean J Med 75:S823-S826, 2008)
Keywords :Chronic lymphocytic leukemia, Alemtuzumab
